Etomoxir

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameEtomoxir
Drug Alias Nameetomoxirum依托莫司etomoxir乙莫克舍BY-754 +[11] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCarnitine palmitoyltransferase 1A inhibitors
TargetsCarnitine palmitoyltransferase 1A
Therapy Area/IndicationsOptic NeuritisMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMeta-Iq
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMeta-Iq
Active IndicationsN/A
Inactive IndicationsOptic NeuritisMultiple Sclerosis

Other Information

ATC CodeN/A
Related LinksWikipedia